Impact of Macrophage Ferroptosis on Health and Disease

Table of Contents

Overview of Ferroptosis and Macrophage Interaction

Ferroptosis is a form of regulated cell death characterized by the accumulation of lipid peroxides to lethal levels, which is distinct from other forms of cell death such as apoptosis and necrosis. It has garnered significant interest due to its implications in various diseases, including cancer, neurodegenerative disorders, and ischemia-reperfusion injuries (Dixon et al., 2012). Macrophages, as innate immune cells, are central to the body’s response to tissue injury and infection, and they play crucial roles in inflammation, phagocytosis, and tissue repair. The interplay between ferroptosis and macrophage function is pivotal in modulating immune responses and influencing disease progression.

Macrophages can be polarized into M1 and M2 phenotypes, which exhibit distinct functions. M1 macrophages are typically pro-inflammatory and are involved in fighting infections, while M2 macrophages are associated with tissue repair and anti-inflammatory responses. Recent studies have revealed that the metabolic pathways of macrophages, including their iron and lipid metabolism, are intricately linked to ferroptosis (Jiang et al., 2024). This relationship highlights the dual role of macrophages as both defenders against pathogens and as potential drivers of tissue damage through ferroptosis.

Mechanisms of Ferroptosis in Macrophages

Ferroptosis in macrophages is primarily regulated through three metabolic pathways: iron metabolism, lipid metabolism, and redox metabolism. Iron is a critical element that catalyzes the formation of reactive oxygen species (ROS) through the Fenton reaction, leading to cellular damage and death. Macrophages manage iron homeostasis by utilizing various transporters, including DMT1 and TFRC, to absorb iron and FPN to export it (Jiang et al., 2024).

Lipid metabolism is another crucial factor in ferroptosis. Polyunsaturated fatty acids (PUFAs) are particularly susceptible to peroxidation, a key event in ferroptosis. The enzymes ACSL4 and LPCAT3 play significant roles in incorporating PUFAs into membrane phospholipids, thus facilitating lipid peroxidation and ferroptosis (Jiang et al., 2024). The redox system, including antioxidants such as glutathione and enzymes like GPX4, helps mitigate oxidative stress and prevent ferroptosis. When these protective mechanisms are overwhelmed, ferroptosis may ensue, leading to macrophage death and subsequent inflammation.

Metabolic Pathway Key Components Role in Ferroptosis
Iron Metabolism DMT1, TFRC, FPN Regulates iron levels; excess Fe2+ promotes ROS production
Lipid Metabolism ACSL4, LPCAT3 Incorporates PUFAs into membranes, initiating lipid peroxidation
Redox Metabolism GPX4, GSH Reduces ROS, preventing ferroptosis

Role of Ferroptosis in Inflammation and Disease Progression

Ferroptosis plays a significant role in modulating inflammation and disease outcomes. Macrophages undergoing ferroptosis can release pro-inflammatory cytokines that contribute to the inflammatory environment, potentially exacerbating conditions such as atherosclerosis and cancer (Jiang et al., 2024). For instance, in atherosclerosis, macrophages that undergo ferroptosis can enhance the inflammatory response and promote plaque instability (Jiang et al., 2024).

Furthermore, the release of damage-associated molecular patterns (DAMPs) from ferroptotic cells can recruit and activate additional macrophages, creating a feedback loop that sustains inflammation (Jiang et al., 2024). In the context of neurodegenerative diseases, ferroptosis has been linked to the loss of neurons and the progression of conditions such as Alzheimer’s disease, where the accumulation of iron and ROS in microglia can lead to increased neuroinflammation (Jiang et al., 2024).

Iron and Lipid Metabolism: Key Factors in Ferroptosis

Iron and lipid metabolism are intrinsically linked to the process of ferroptosis. Iron can promote ferroptosis through the Fenton reaction, generating ROS that lead to lipid peroxidation and subsequent cell death. Macrophages play a crucial role in modulating iron levels; their ability to sequester iron through ferritin and export it via FPN is important for preventing excess iron accumulation that could trigger ferroptosis (Jiang et al., 2024).

Lipid metabolism also directly influences ferroptosis. The incorporation of PUFAs into cell membranes makes them vulnerable to peroxidation, and the metabolic pathways that regulate these lipids are crucial for maintaining cellular integrity. The activity of enzymes such as ACSL4 and LPCAT3 directly affects the susceptibility of macrophages to undergo ferroptosis, highlighting the importance of lipid metabolism in this process (Jiang et al., 2024).

Factor Function Impact on Ferroptosis
Iron Catalyzes ROS production Excess promotes ferroptosis
Lipids Source of PUFAs for membranes Increased PUFA incorporation enhances ferroptosis
Enzymes (ACSL4, LPCAT3) Regulate lipid metabolism Affect susceptibility to oxidative stress

Therapeutic Approaches Targeting Macrophage Ferroptosis

Given the relationship between ferroptosis and macrophage function, therapeutic strategies targeting this process may offer novel approaches to treat various diseases. Potential interventions include:

  1. Modulation of Iron Metabolism: Agents that can regulate iron levels, such as iron chelators, may help prevent ferroptosis in macrophages and reduce inflammation.
  2. Antioxidant Therapies: Enhancing the redox capacity of macrophages through antioxidants like GSH or GPX4 activators may mitigate ferroptotic stress.
  3. Lipid Metabolism Modulators: Compounds that influence lipid metabolism, such as inhibitors of ACSL4, could help reduce the susceptibility of macrophages to ferroptosis, potentially benefiting diseases characterized by chronic inflammation.

Ferroptosis represents a promising therapeutic target for modulating macrophage activity in various diseases. By understanding the mechanisms involved in ferroptosis and its impact on macrophages, researchers can develop targeted therapies that improve health outcomes in conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders.

FAQ Section

What is ferroptosis?
Ferroptosis is a form of regulated cell death characterized by the accumulation of lipid peroxides to lethal levels, driven by iron-dependent processes.

How do macrophages relate to ferroptosis?
Macrophages can influence the process of ferroptosis through their metabolic activities involving iron and lipid metabolism, and they can also undergo ferroptosis themselves under certain conditions.

What role does iron play in ferroptosis?
Iron can catalyze the production of reactive oxygen species (ROS), which promote lipid peroxidation and lead to ferroptosis. Macrophages regulate iron levels to prevent excess accumulation that could trigger ferroptosis.

How can therapeutic strategies target macrophage ferroptosis?
Therapeutic strategies may include modulation of iron metabolism, antioxidant therapies, and lipid metabolism modulators to mitigate ferroptotic stress and improve health outcomes.

Why is understanding ferroptosis important in disease contexts?
Understanding ferroptosis is crucial because it plays a significant role in modulating inflammation and disease progression in various conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders.

References

  1. Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., … & Stockwell, B. R. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060-1072. https://doi.org/10.1016/j.cell.2012.03.042

  2. Jiang, Q., Wan, R., Jiang, J., Li, T., Li, Y., Yu, S., Zhao, B., & Li, Y. (2024). Interaction between macrophages and ferroptosis: Metabolism, function, and diseases

  3. Yu, Y. L., & Jiang, Q. (2025). Advances in Pathophysiological Mechanisms of Degenerative Aortic Valve Disease. Cardiology Research, 1923-2829. https://doi.org/10.14740/cr2012

  4. De Masi De Luca, G., Palama, Z., Zefferino, L., Longo, S., Barba, F., Robles, A. G., … & Fusco, L. (2025). Effect of Dapagliflozin on Ventricular Arrhythmic Events in Heart Failure Patients With an Implantable Cardioverter Defibrillator. Cardiology Research. https://doi.org/10.14740/cr2018

  5. Amaranthus, J. (2025). Physiological Ventricular Pacing from the Right Side of the Septum by Engaging the Subendocardial Purkinje Network

  6. Long-Term Clinical Outcomes in Patients With Transthyretin Cardiac Amyloidosis Versus Non-Ischemic Cardiomyopathy. (2025). Cardiology Research. https://doi.org/10.14740/cr2050

Written by

Charles has a Bachelor’s degree in Kinesiology from the University of Texas. With a focus on physical fitness and rehabilitation, he shares practical health advice through his writing. In his free time, Charles is an avid runner and a volunteer coach.